Last Posted: Apr 25, 2019
- Enantiospecific pharmacogenomics of fluvastatin.
Hirvensalo Päivi et al. Clinical pharmacology and therapeutics 2019 Apr - Pharmacogenomics guidelines: current status and future development.
Guo Chengxian et al. Clinical and experimental pharmacology & physiology 2019 Apr - Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study.
Dressler Lynn G et al. Pharmacogenomics 2019 Apr - Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
Waldman Larissa et al. Pharmacogenomics 2019 Apr - Population Pharmacogenomics for Precision Public Health in Colombia.
Nagar Shashwat Deepali et al. Frontiers in genetics 2019 10241 - Prognostic impact of genetic variants of CYP19A1 and UGT2B17 in a randomized trial for endocrine-responsive postmenopausal breast cancer.
Johansson Harriet et al. The pharmacogenomics journal 2019 Apr - Actionable Pharmacogenetic Variation in the Slovenian Genomic Database.
Hocevar Keli et al. Frontiers in pharmacology 2019 10240 - Personal genome testing on physicians improves attitudes on pharmacogenomic approaches.
Lee Kye Hwa et al. PloS one 2019 14(3) e0213860 - Pharmacogenomics of chronic obstructive pulmonary disease.
Hersh Craig P et al. Expert review of respiratory medicine 2019 Mar - The role of pharmacogenomics in adverse drug reactions.
Cacabelos Ramón et al. Expert review of clinical pharmacology 2019 Mar
.png)
No hay comentarios:
Publicar un comentario